RecruitingNCT05067179

Analysis of Human ALS Tissues and Registry of ALS Patients


Sponsor

University of Illinois at Chicago

Enrollment

40 participants

Start Date

Sep 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

Amyotrophic Lateral Sclerosis (ALS), often referred to as Lou Gehrig's Disease, is a progressive, terminal condition of muscle weakness that is associated with degeneration of neurons in the spinal cord and brain. This devastating disorder afflicts people in the prime of their lives. At the present time, there are no cures for this disorder, and current treatments are marginal at best. Despite years of intensive research, a fundamental understanding of this disease is still lacking. There is a need to identify both reliable markers of disease progression and effective treatments. The goal of this research is to bring a greater understanding of ALS patients closer to the research studies that can lead to new hypotheses and approaches.


Eligibility

Min Age: 18 YearsMax Age: 90 Years

Inclusion Criteria3

  • Patients over the age of 18
  • Established diagnosis of ALS
  • Able and willing to give written informed consent and must authorize release and use of protected health information

Exclusion Criteria2

  • Patients below the age of 18
  • No diagnosis of ALS

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University of Illinois at Chicago

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05067179


Related Trials